Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Earth Science TechETST Equity-to-Asset is 0.71 as of Jun. 2026. The stock has 4 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Earth Science Tech ranks better than 65.97% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Earth Science Tech's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $7.34 Mil. Earth Science Tech's Total Assets for the quarter that ended in Jun. 2026 was $10.37 Mil.
Therefore, Earth Science Tech's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.71.
The historical rank and industry rank for Earth Science Tech's Equity-to-Asset or its related term are showing as below:
ETST'
s Equity-to-Asset Range Over the Past 10 Years
Min: -128.74 Med: -0.11 Max: 0.78
Current: 0.71
During the past 13 years, the highest Equity to Asset Ratio of Earth Science Tech was 0.78. The lowest was -128.74. And the median was -0.11.
ETST's Equity-to-Asset is ranked better than 65.97% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs ETST: 0.71
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Earth Science Tech Equity-to-Asset Related Terms
Earth Science Tech Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Earth Science Tech's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETST vs IXHL, SCYX, INIS: Equity-to-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Earth Science Tech's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earth Science Tech Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Earth Science Tech's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Earth Science Tech's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Earth Science Tech's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earth Science Tech (ETST) has a Equity-to-Asset of 0.71 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Earth Science Tech and its competitors. According to the industry distribution chart, Earth Science Tech ranks #342 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 34%.
Is Earth Science Tech's Equity-to-Asset too high?
Earth Science Tech's current Equity-to-Asset is 0.71. The Drug Manufacturers industry median Equity-to-Asset is 0.61. Earth Science Tech's value of 0.71 is 16.4% above this industry median. Based on the distribution chart, Earth Science Tech ranks #342 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Earth Science Tech's Equity-to-Asset compare to IXHL and SCYX?
According to the Drug Manufacturers industry distribution chart, Earth Science Tech ranks #342 out of 1005 companies for Equity-to-Asset. This puts Earth Science Tech in the upper half of its industry. The industry median Equity-to-Asset is 0.61. Earth Science Tech's value of 0.71 is 16.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earth Science Tech's current Equity-to-Asset of 0.71 is 16.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Earth Science Tech and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Science Tech's current Equity-to-Asset is 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Science Tech stock overvalued right now?
Earth Science Tech (ETST) has a current Equity-to-Asset of 0.71. The current Equity-to-Asset is 0.71 and 16.4% above the Drug Manufacturers industry median of 0.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Earth Science Tech (ETST), the current Equity-to-Asset is 0.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Earth Science Tech Inc is a diversified holding company. The company focuses on the health and wellness sector. The Company's principal operating plan is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of the Company's value proposition is the seamless integration of patient care, from consultation to fulfillment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ETST has been successfully added to your 
